CN Stock MarketDetailed Quotes

000590 Tus-Pharmaceutical Group

Watchlist
  • 5.33
  • +0.21+4.10%
Market Closed Jul 5 15:00 CST
1.28BMarket Cap123.95P/E (TTM)

Tus-Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-23.82%77.09M
15.44%404.65M
16.10%274.63M
22.35%190.05M
10.76%101.2M
16.54%350.53M
9.31%236.55M
4.59%155.33M
19.07%91.37M
9.34%300.77M
Operating revenue
-23.82%77.09M
15.44%404.65M
16.10%274.63M
22.35%190.05M
10.76%101.2M
16.54%350.53M
9.31%236.55M
4.59%155.33M
19.07%91.37M
9.34%300.77M
Other operating revenue
----
52.93%6.12M
----
114.09%3.11M
----
14.62%4M
----
26.85%1.45M
----
26.46%3.49M
Total operating cost
-9.68%85.67M
17.31%392.81M
20.73%268.57M
25.71%183.61M
21.10%94.85M
24.39%334.86M
23.23%222.46M
20.31%146.06M
28.94%78.32M
7.67%269.2M
Operating cost
-19.73%37.95M
12.38%192.53M
13.19%130.21M
18.50%88.25M
9.81%47.28M
27.37%171.33M
19.32%115.03M
15.64%74.47M
28.46%43.06M
10.43%134.52M
Operating tax surcharges
-15.07%1.82M
8.33%8.72M
7.73%6.25M
4.76%4.22M
0.33%2.14M
15.88%8.05M
18.40%5.8M
18.93%4.03M
25.01%2.14M
-9.12%6.95M
Operating expense
-12.87%19.97M
38.76%89.82M
51.72%64.76M
59.43%45.76M
52.11%22.92M
40.24%64.73M
39.19%42.68M
40.79%28.7M
51.61%15.07M
20.53%46.16M
Administration expense
19.21%22.84M
6.85%86.82M
4.22%56.56M
7.96%38.27M
15.33%19.16M
2.11%81.25M
13.07%54.27M
6.27%35.45M
5.88%16.61M
-0.03%79.57M
Financial expense
78.27%549.95K
158.43%2.11M
150.13%1.54M
153.03%1.02M
125.05%308.49K
42.61%-3.6M
41.89%-3.07M
50.66%-1.92M
36.71%-1.23M
9.00%-6.28M
-Interest expense (Financial expense)
-9.35%952.72K
286.52%4.46M
528.10%3.5M
527.10%2.43M
987.63%1.05M
144.75%1.15M
835.11%556.61K
843.16%388.19K
2,182.71%96.64K
3,441.11%471.7K
-Interest Income (Financial expense)
39.12%-418.23K
34.90%-2.24M
28.41%-1.86M
13.13%-1.36M
24.62%-686.96K
20.82%-3.44M
25.39%-2.59M
42.56%-1.56M
30.22%-911.28K
2.68%-4.35M
Research and development
-16.54%2.53M
-2.17%12.82M
19.56%9.25M
14.31%6.09M
13.32%3.04M
58.07%13.1M
32.56%7.74M
41.72%5.33M
46.37%2.68M
-13.60%8.29M
Credit Impairment Loss
118.33%826.8
-915.12%-7.96M
89.00%-156.5K
70.64%-425.72K
84.81%-4.51K
894.37%976.26K
-374.12%-1.42M
-470.75%-1.45M
-108.13%-29.7K
-90.57%98.18K
Asset Impairment Loss
----
-616.81%-6.38M
----
----
----
54.64%-890.25K
----
----
----
34.90%-1.96M
Other net revenue
-19.22%1.56M
18.85%8.32M
-43.20%3.44M
-47.99%2.54M
8.42%1.93M
-35.05%7M
-35.66%6.05M
-25.46%4.89M
-67.96%1.78M
294.53%10.78M
Fair value change income
----
1,648.91%1.9M
----
----
----
-25.59%108.64K
----
----
----
--145.99K
Invest income
-74.05%89.95K
-66.73%885.86K
-73.68%612.08K
-76.98%461.25K
-39.92%346.63K
-16.31%2.66M
18.06%2.33M
565.65%2M
400.96%576.95K
736.90%3.18M
Asset deal income
----
71,934.05%13.33M
-93.62%154.3K
-93.30%168.51K
3,995.90%149.08K
-96.39%18.5K
356.91%2.42M
433.22%2.52M
---3.83K
599.65%511.99K
Other revenue
2.08%1.47M
58.65%6.55M
3.57%2.83M
28.37%2.34M
16.37%1.44M
-53.14%4.13M
-57.26%2.73M
-66.23%1.82M
-75.64%1.23M
107.05%8.81M
Operating profit
-184.84%-7.02M
-11.08%20.16M
-52.87%9.49M
-36.56%8.98M
-44.18%8.28M
-46.47%22.67M
-55.52%20.14M
-57.95%14.16M
-31.19%14.82M
52.43%42.35M
Add:Non operating Income
936.89%8.72K
25,302.04%9.72M
26.48%15.73K
205.46%12.37K
--840.64
-1.18%38.28K
3.38%12.44K
-43.75%4.05K
----
-60.47%38.73K
Less:Non operating expense
3,220.73%56.97K
-75.60%203.74K
176.88%17.93K
-61.31%2.36K
164.28%1.72K
50.15%835.14K
-98.36%6.48K
-95.84%6.11K
-99.24%649.13
130.87%556.19K
Total profit
-185.43%-7.07M
35.67%29.68M
-52.89%9.49M
-36.48%8.99M
-44.18%8.27M
-47.71%21.88M
-55.13%20.15M
-57.78%14.16M
-30.94%14.82M
51.35%41.84M
Less:Income tax cost
-28.11%1.2M
28.07%4.79M
-32.62%2.91M
-1.59%2.54M
-29.80%1.67M
-41.55%3.74M
-25.88%4.33M
-40.56%2.58M
136.67%2.37M
30.04%6.4M
Net profit
SL-8.27M
37.24%24.89M
-58.43%6.58M
-44.25%6.46M
-46.92%6.61M
-48.82%18.14M
-59.50%15.82M
-60.33%11.58M
-39.15%12.45M
55.96%35.44M
Net profit from continuing operation
-225.09%-8.27M
37.24%24.89M
-58.43%6.58M
-44.25%6.46M
-46.92%6.61M
-48.82%18.14M
-59.50%15.82M
-60.33%11.58M
-39.15%12.45M
55.96%35.44M
Less:Minority Profit
-24.71%17.85K
-1,436.47%-356.58K
18.61%147.11K
165.50%74.48K
146.35%23.71K
3,736.94%26.68K
--124.02K
--28.05K
---51.15K
---733.6
Net profit of parent company owners
-225.81%-8.28M
39.41%25.25M
-59.04%6.43M
-44.76%6.38M
-47.33%6.58M
-48.90%18.11M
-59.81%15.7M
-60.43%11.55M
-38.90%12.5M
55.96%35.44M
Earning per share
Basic earning per share
-225.82%-0.0346
39.42%0.1054
-58.99%0.0269
-44.61%0.0267
-47.32%0.0275
-48.92%0.0756
-59.78%0.0656
-60.46%0.0482
-38.88%0.0522
55.95%0.148
Diluted earning per share
-225.82%-0.0346
39.42%0.1054
-58.99%0.0269
-44.61%0.0267
-47.32%0.0275
-48.92%0.0756
-59.78%0.0656
-60.46%0.0482
-38.88%0.0522
55.95%0.148
Other composite income
Total composite income
-225.09%-8.27M
37.24%24.89M
-58.43%6.58M
-44.25%6.46M
-46.92%6.61M
-48.82%18.14M
-59.50%15.82M
-60.33%11.58M
-39.15%12.45M
55.96%35.44M
Total composite income of parent company owners
-225.81%-8.28M
39.41%25.25M
-59.04%6.43M
-44.76%6.38M
-47.33%6.58M
-48.90%18.11M
-59.81%15.7M
-60.43%11.55M
-38.90%12.5M
55.96%35.44M
Total composite income of minority owners
-24.71%17.85K
-1,436.47%-356.58K
18.61%147.11K
165.50%74.48K
146.35%23.71K
3,736.94%26.68K
--124.02K
--28.05K
---51.15K
---733.6
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -23.82%77.09M15.44%404.65M16.10%274.63M22.35%190.05M10.76%101.2M16.54%350.53M9.31%236.55M4.59%155.33M19.07%91.37M9.34%300.77M
Operating revenue -23.82%77.09M15.44%404.65M16.10%274.63M22.35%190.05M10.76%101.2M16.54%350.53M9.31%236.55M4.59%155.33M19.07%91.37M9.34%300.77M
Other operating revenue ----52.93%6.12M----114.09%3.11M----14.62%4M----26.85%1.45M----26.46%3.49M
Total operating cost -9.68%85.67M17.31%392.81M20.73%268.57M25.71%183.61M21.10%94.85M24.39%334.86M23.23%222.46M20.31%146.06M28.94%78.32M7.67%269.2M
Operating cost -19.73%37.95M12.38%192.53M13.19%130.21M18.50%88.25M9.81%47.28M27.37%171.33M19.32%115.03M15.64%74.47M28.46%43.06M10.43%134.52M
Operating tax surcharges -15.07%1.82M8.33%8.72M7.73%6.25M4.76%4.22M0.33%2.14M15.88%8.05M18.40%5.8M18.93%4.03M25.01%2.14M-9.12%6.95M
Operating expense -12.87%19.97M38.76%89.82M51.72%64.76M59.43%45.76M52.11%22.92M40.24%64.73M39.19%42.68M40.79%28.7M51.61%15.07M20.53%46.16M
Administration expense 19.21%22.84M6.85%86.82M4.22%56.56M7.96%38.27M15.33%19.16M2.11%81.25M13.07%54.27M6.27%35.45M5.88%16.61M-0.03%79.57M
Financial expense 78.27%549.95K158.43%2.11M150.13%1.54M153.03%1.02M125.05%308.49K42.61%-3.6M41.89%-3.07M50.66%-1.92M36.71%-1.23M9.00%-6.28M
-Interest expense (Financial expense) -9.35%952.72K286.52%4.46M528.10%3.5M527.10%2.43M987.63%1.05M144.75%1.15M835.11%556.61K843.16%388.19K2,182.71%96.64K3,441.11%471.7K
-Interest Income (Financial expense) 39.12%-418.23K34.90%-2.24M28.41%-1.86M13.13%-1.36M24.62%-686.96K20.82%-3.44M25.39%-2.59M42.56%-1.56M30.22%-911.28K2.68%-4.35M
Research and development -16.54%2.53M-2.17%12.82M19.56%9.25M14.31%6.09M13.32%3.04M58.07%13.1M32.56%7.74M41.72%5.33M46.37%2.68M-13.60%8.29M
Credit Impairment Loss 118.33%826.8-915.12%-7.96M89.00%-156.5K70.64%-425.72K84.81%-4.51K894.37%976.26K-374.12%-1.42M-470.75%-1.45M-108.13%-29.7K-90.57%98.18K
Asset Impairment Loss -----616.81%-6.38M------------54.64%-890.25K------------34.90%-1.96M
Other net revenue -19.22%1.56M18.85%8.32M-43.20%3.44M-47.99%2.54M8.42%1.93M-35.05%7M-35.66%6.05M-25.46%4.89M-67.96%1.78M294.53%10.78M
Fair value change income ----1,648.91%1.9M-------------25.59%108.64K--------------145.99K
Invest income -74.05%89.95K-66.73%885.86K-73.68%612.08K-76.98%461.25K-39.92%346.63K-16.31%2.66M18.06%2.33M565.65%2M400.96%576.95K736.90%3.18M
Asset deal income ----71,934.05%13.33M-93.62%154.3K-93.30%168.51K3,995.90%149.08K-96.39%18.5K356.91%2.42M433.22%2.52M---3.83K599.65%511.99K
Other revenue 2.08%1.47M58.65%6.55M3.57%2.83M28.37%2.34M16.37%1.44M-53.14%4.13M-57.26%2.73M-66.23%1.82M-75.64%1.23M107.05%8.81M
Operating profit -184.84%-7.02M-11.08%20.16M-52.87%9.49M-36.56%8.98M-44.18%8.28M-46.47%22.67M-55.52%20.14M-57.95%14.16M-31.19%14.82M52.43%42.35M
Add:Non operating Income 936.89%8.72K25,302.04%9.72M26.48%15.73K205.46%12.37K--840.64-1.18%38.28K3.38%12.44K-43.75%4.05K-----60.47%38.73K
Less:Non operating expense 3,220.73%56.97K-75.60%203.74K176.88%17.93K-61.31%2.36K164.28%1.72K50.15%835.14K-98.36%6.48K-95.84%6.11K-99.24%649.13130.87%556.19K
Total profit -185.43%-7.07M35.67%29.68M-52.89%9.49M-36.48%8.99M-44.18%8.27M-47.71%21.88M-55.13%20.15M-57.78%14.16M-30.94%14.82M51.35%41.84M
Less:Income tax cost -28.11%1.2M28.07%4.79M-32.62%2.91M-1.59%2.54M-29.80%1.67M-41.55%3.74M-25.88%4.33M-40.56%2.58M136.67%2.37M30.04%6.4M
Net profit SL-8.27M37.24%24.89M-58.43%6.58M-44.25%6.46M-46.92%6.61M-48.82%18.14M-59.50%15.82M-60.33%11.58M-39.15%12.45M55.96%35.44M
Net profit from continuing operation -225.09%-8.27M37.24%24.89M-58.43%6.58M-44.25%6.46M-46.92%6.61M-48.82%18.14M-59.50%15.82M-60.33%11.58M-39.15%12.45M55.96%35.44M
Less:Minority Profit -24.71%17.85K-1,436.47%-356.58K18.61%147.11K165.50%74.48K146.35%23.71K3,736.94%26.68K--124.02K--28.05K---51.15K---733.6
Net profit of parent company owners -225.81%-8.28M39.41%25.25M-59.04%6.43M-44.76%6.38M-47.33%6.58M-48.90%18.11M-59.81%15.7M-60.43%11.55M-38.90%12.5M55.96%35.44M
Earning per share
Basic earning per share -225.82%-0.034639.42%0.1054-58.99%0.0269-44.61%0.0267-47.32%0.0275-48.92%0.0756-59.78%0.0656-60.46%0.0482-38.88%0.052255.95%0.148
Diluted earning per share -225.82%-0.034639.42%0.1054-58.99%0.0269-44.61%0.0267-47.32%0.0275-48.92%0.0756-59.78%0.0656-60.46%0.0482-38.88%0.052255.95%0.148
Other composite income
Total composite income -225.09%-8.27M37.24%24.89M-58.43%6.58M-44.25%6.46M-46.92%6.61M-48.82%18.14M-59.50%15.82M-60.33%11.58M-39.15%12.45M55.96%35.44M
Total composite income of parent company owners -225.81%-8.28M39.41%25.25M-59.04%6.43M-44.76%6.38M-47.33%6.58M-48.90%18.11M-59.81%15.7M-60.43%11.55M-38.90%12.5M55.96%35.44M
Total composite income of minority owners -24.71%17.85K-1,436.47%-356.58K18.61%147.11K165.50%74.48K146.35%23.71K3,736.94%26.68K--124.02K--28.05K---51.15K---733.6
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg